BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

499 related articles for article (PubMed ID: 11134009)

  • 1. A critical role for phosphoinositide 3-kinase upstream of Gab1 and SHP2 in the activation of ras and mitogen-activated protein kinases by epidermal growth factor.
    Yart A; Laffargue M; Mayeux P; Chretien S; Peres C; Tonks N; Roche S; Payrastre B; Chap H; Raynal P
    J Biol Chem; 2001 Mar; 276(12):8856-64. PubMed ID: 11134009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A function for phosphoinositide 3-kinase beta lipid products in coupling beta gamma to Ras activation in response to lysophosphatidic acid.
    Yart A; Roche S; Wetzker R; Laffargue M; Tonks N; Mayeux P; Chap H; Raynal P
    J Biol Chem; 2002 Jun; 277(24):21167-78. PubMed ID: 11916960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Requirement of SHP2 binding to Grb2-associated binder-1 for mitogen-activated protein kinase activation in response to lysophosphatidic acid and epidermal growth factor.
    Cunnick JM; Dorsey JF; Munoz-Antonia T; Mei L; Wu J
    J Biol Chem; 2000 May; 275(18):13842-8. PubMed ID: 10788507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel role for Gab1 and SHP2 in epidermal growth factor-induced Ras activation.
    Montagner A; Yart A; Dance M; Perret B; Salles JP; Raynal P
    J Biol Chem; 2005 Feb; 280(7):5350-60. PubMed ID: 15574420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Signal strength dictates phosphoinositide 3-kinase contribution to Ras/extracellular signal-regulated kinase 1 and 2 activation via differential Gab1/Shp2 recruitment: consequences for resistance to epidermal growth factor receptor inhibition.
    Sampaio C; Dance M; Montagner A; Edouard T; Malet N; Perret B; Yart A; Salles JP; Raynal P
    Mol Cell Biol; 2008 Jan; 28(2):587-600. PubMed ID: 18025104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Receptor-specific regulation of phosphatidylinositol 3'-kinase activation by the protein tyrosine phosphatase Shp2.
    Zhang SQ; Tsiaras WG; Araki T; Wen G; Minichiello L; Klein R; Neel BG
    Mol Cell Biol; 2002 Jun; 22(12):4062-72. PubMed ID: 12024020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Noonan syndrome-associated SHP2/PTPN11 mutants cause EGF-dependent prolonged GAB1 binding and sustained ERK2/MAPK1 activation.
    Fragale A; Tartaglia M; Wu J; Gelb BD
    Hum Mutat; 2004 Mar; 23(3):267-77. PubMed ID: 14974085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Signaling complexes and protein-protein interactions involved in the activation of the Ras and phosphatidylinositol 3-kinase pathways by the c-Ret receptor tyrosine kinase.
    Besset V; Scott RP; Ibáñez CF
    J Biol Chem; 2000 Dec; 275(50):39159-66. PubMed ID: 10995764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ERK negatively regulates the epidermal growth factor-mediated interaction of Gab1 and the phosphatidylinositol 3-kinase.
    Yu CF; Liu ZX; Cantley LG
    J Biol Chem; 2002 May; 277(22):19382-8. PubMed ID: 11896055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The protein tyrosine phosphatase, Shp2, is required for the complete activation of the RAS/MAPK pathway by brain-derived neurotrophic factor.
    Easton JB; Royer AR; Middlemas DS
    J Neurochem; 2006 May; 97(3):834-45. PubMed ID: 16573649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of the mitogen-activated protein kinase signaling pathway by SHP2.
    Cunnick JM; Meng S; Ren Y; Desponts C; Wang HG; Djeu JY; Wu J
    J Biol Chem; 2002 Mar; 277(11):9498-504. PubMed ID: 11779868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin 6 inhibits proliferation and, in cooperation with an epidermal growth factor receptor autocrine loop, increases migration of T47D breast cancer cells.
    Badache A; Hynes NE
    Cancer Res; 2001 Jan; 61(1):383-91. PubMed ID: 11196191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The phosphotyrosine phosphatase SHP2 is a critical mediator of transformation induced by the oncogenic fibroblast growth factor receptor 3.
    Agazie YM; Movilla N; Ischenko I; Hayman MJ
    Oncogene; 2003 Oct; 22(44):6909-18. PubMed ID: 14534538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphotyrosines 627 and 659 of Gab1 constitute a bisphosphoryl tyrosine-based activation motif (BTAM) conferring binding and activation of SHP2.
    Cunnick JM; Mei L; Doupnik CA; Wu J
    J Biol Chem; 2001 Jun; 276(26):24380-7. PubMed ID: 11323411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Gab1 docking protein links the b cell antigen receptor to the phosphatidylinositol 3-kinase/Akt signaling pathway and to the SHP2 tyrosine phosphatase.
    Ingham RJ; Santos L; Dang-Lawson M; Holgado-Madruga M; Dudek P; Maroun CR; Wong AJ; Matsuuchi L; Gold MR
    J Biol Chem; 2001 Apr; 276(15):12257-65. PubMed ID: 11278704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Roles of Gab1 and SHP2 in paxillin tyrosine dephosphorylation and Src activation in response to epidermal growth factor.
    Ren Y; Meng S; Mei L; Zhao ZJ; Jove R; Wu J
    J Biol Chem; 2004 Feb; 279(9):8497-505. PubMed ID: 14665621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Participation of both Gab1 and Gab2 in the activation of the ERK/MAPK pathway by epidermal growth factor.
    Meng S; Chen Z; Munoz-Antonia T; Wu J
    Biochem J; 2005 Oct; 391(Pt 1):143-51. PubMed ID: 15952937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gab1 and SHP-2 promote Ras/MAPK regulation of epidermal growth and differentiation.
    Cai T; Nishida K; Hirano T; Khavari PA
    J Cell Biol; 2002 Oct; 159(1):103-12. PubMed ID: 12370245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The docking protein Gab1 is the primary mediator of EGF-stimulated activation of the PI-3K/Akt cell survival pathway.
    Mattoon DR; Lamothe B; Lax I; Schlessinger J
    BMC Biol; 2004 Nov; 2():24. PubMed ID: 15550174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of the Grb2-associated binder 1/SHP-2 interaction in cell growth and transformation.
    Holgado-Madruga M; Wong AJ
    Cancer Res; 2004 Mar; 64(6):2007-15. PubMed ID: 15026337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.